Target Name: PIGB
NCBI ID: G9488
Review Report on PIGB Target / Biomarker Content of Review Report on PIGB Target / Biomarker
PIGB
Other Name(s): phosphatidylinositol glycan anchor biosynthesis class B | EIEE80 | GPI mannosyltransferase III | DEE80 | dol-P-Man dependent GPI mannosyltransferase III | GPI-MT-III | GPI mannosyltransferase 3 | dol-P-Man dependent GPI mannosyltransferase | phosphatidylinositol glycan, class B | Phosphatidylinositol glycan anchor biosynthesis class B | Phosphatidylinositol-glycan biosynthesis class B protein | PIG-B | PIGB_HUMAN | phosphatidylinositol-glycan biosynthesis class B protein

Biosynthesis of PhosphatidylSerine

Phosphatidylinositol glycan (PIG) 鈥嬧?媋nchor biosynthesis class B (Biosynthesis class II) is a crucial step in the production of one of the main components of cell membrane-phosphatidylserine (phosphatidylinositol). The cell membrane is composed of a lipid bilayer, and phosphatidylserine is the basic skeleton of the cell membrane. Therefore, the biosynthesis of phosphatidylserine is the basis of cell membrane structure and function.

PIGB biosynthesis class B is a complex biosynthetic pathway involving the participation of multiple enzymes and complex metabolic pathways. In PIGB biosynthesis class B, the biosynthesis of phosphatidylserine begins with acetyl-coenzyme A (Acetyl-CoA), an important metabolite and the main acetyl-CoA produced in cells. Acetyl-CoA is further converted into acetyl-CoA thiokinase, which is involved in the sulfur metabolism of acetyl-CoA.

Another key step in PIGB biosynthesis class B is the synthesis of phosphatidyl acetyl coenzyme A (Phosphatidyl-CoA). Phosphatidyl acetyl-CoA is the precursor molecule of phosphatidylserine, and its synthesis requires the participation of acetyl-CoA and phosphatidyl-CoA. Acetyl-CoA is converted into phosphatidyl-CoA through a series of metabolic reactions, which is further synthesized into phosphatidylserine.

PIGB biosynthesis class B also involves the participation of a variety of coenzymes, including thioacetyl coenzyme A (Thiokinase), thioacetyl coenzyme A (Sphingomyelinase), and disulfide phosphatidyltransferase (Dipeptidyltransferase). These coenzymes play an important role in PIGB biosynthesis class B, participating in substrate conversion, S-adenylation and other reactions, thereby completing the biosynthesis of phosphatidylserine.

The research results of PIGB biosynthesis class B show that PIG is an important cell signaling molecule, and its biosynthesis process is regulated by a variety of enzymes. In addition, PIG also has a variety of biological functions, such as regulating immune responses and participating in cell proliferation. Therefore, PIGB biosynthesis class B is a promising research field and one of the targets for future drug development.

In drug research and development, PIGB biosynthesis class B has attracted widespread research interest as an important research object. Many researchers are committed to in-depth study of the molecular mechanism of PIGB biosynthesis class B and the application value of this biosynthesis pathway in drugs. With the continuous development of science and technology, PIGB biosynthesis class B, as a new drug target, is expected to bring more help to human health.

Protein Name: Phosphatidylinositol Glycan Anchor Biosynthesis Class B

Functions: Mannosyltransferase involved in glycosylphosphatidylinositol-anchor biosynthesis. Transfers the third alpha-1,2-mannose to Man2-GlcN-acyl-PI during GPI precursor assembly

The "PIGB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PIGB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PIGBOS1 | PIGC | PIGF | PIGG | PIGH | PIGK | PIGL | PIGM | PIGN | PIGO | PIGP | PIGQ | PIGR | PIGS | PIGT | PIGU | PIGV | PIGW | PIGX | PIGY | PIGZ | PIH1D1 | PIH1D2 | PIK3AP1 | PIK3C2A | PIK3C2B | PIK3C2G | PIK3C3 | PIK3CA | PIK3CA-DT | PIK3CB | PIK3CD | PIK3CD-AS1 | PIK3CD-AS2 | PIK3CG | PIK3IP1 | PIK3IP1-DT | PIK3R1 | PIK3R2 | PIK3R3 | PIK3R4 | PIK3R5 | PIK3R6 | PIKFYVE | PILRA | PILRB | Pim Kinase | PIM1 | PIM2 | PIM3 | PIMREG | PIN1 | PIN1-DT | PIN1P1 | PIN4 | PINCR | PINK1 | PINK1-AS | PINLYP | PINX1 | PIP | PIP4K2A | PIP4K2B | PIP4K2C | PIP4P1 | PIP4P2 | PIP5K1A | PIP5K1B | PIP5K1C | PIP5K1P1 | PIP5KL1 | PIPOX | PIPSL | PIR | PIR-FIGF | PIRAT1 | PIRT | PISD | PISRT1 | PITHD1 | PITPNA | PITPNA-AS1 | PITPNB | PITPNC1 | PITPNM1 | PITPNM2 | PITPNM2-AS1 | PITPNM3 | PITRM1 | PITRM1-AS1 | PITX1 | PITX1-AS1 | PITX2 | PITX3 | PIWIL1 | PIWIL2 | PIWIL2-DT | PIWIL3 | PIWIL4 | PIWIL4-AS1